ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Pepperstone

Trade Now

Pepperstone
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
S&P ASX 200
7,682.40
0.70%
S&P ASX All Technology
3,019.20
0.10%
Brent Oil
83.595
0.57%
US Dollar vs AUD
1.50877
-0.27%
Bitcoin
64,096.74
0.15%
Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. NexGel Inc (NXGL)

  7. NexGel Inc (NXGL) News

NXGL NexGel Inc

2.22
0.00 (0.00%)
Pre Market
Last Updated: 18:00:00
Delayed by 15 minutes
Share Name Share Symbol Market Stock Type
NexGel Inc NXGL NASDAQ Common Stock
  Price Change Price Change % Share Price Last Trade
Upgrade Icon
0.00 0.00% 2.22 18:00:00
Open Price Low Price High Price Close Price Previous Close
2.22
more quote information »

Recent News

Date Time Source Heading
18/4/202422:00GLOBENEXGEL to Present at the Planet MicroCap Showcase: VEGAS..
01/4/202422:50GLOBENEXGEL Reports Full Year 2023 Revenue of $4.1 Million, an..
28/3/202400:00GLOBENEXGEL Reschedules Fourth Quarter and Full Year 2023..
22/3/202400:00GLOBENEXGEL to Report Fourth Quarter and Full Year 2023 Financial..
06/3/202401:07EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/3/202401:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/3/202401:04EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/3/202400:30GLOBENEXGEL to Present at the iAccess Alpha Best Ideas Spring..
22/2/202408:17EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
22/2/202408:15EDGAR2Form 8-K - Current report
22/2/202408:05GLOBENEXGEL Announces $975,000 Registered Direct Offering Led by..
01/2/202401:05EDGAR2Form 8-K - Current report
19/1/202401:00GLOBENEXGEL to Present at The Microcap Conference, January 30th..
17/1/202408:30EDGAR2Form 8-K - Current report
10/1/202400:30GLOBENEXGEL Subsidiary, CG Converting and Packaging, Begins..
30/12/202308:30EDGAR2Form 8-K - Current report
27/12/202308:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/12/202308:52EDGAR2Form 8-K - Current report
12/12/202300:15EDGAR2Form 8-K - Current report
12/12/202300:00GLOBENEXGEL Announces Partnership with STADA to Distribute and..
06/12/202300:10EDGAR2Form 8-K - Current report
06/12/202300:00GLOBENEXGEL Acquires Kenkoderm Psoriasis Skincare Line
14/11/202309:15EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
14/11/202309:10EDGAR2Form 8-K - Current report
14/11/202308:05GLOBENEXGEL Reports Record Third Quarter 2023 Revenue of $1.2..
03/11/202300:00GLOBENEXGEL to Report Third Quarter 2023 Financial Results on..
30/10/202323:30EDGAR2Form 8-K - Current report
30/10/202323:00GLOBENEXGEL Secures Supply Agreement with AbbVie
26/9/202323:49GLOBENEXGEL to Participate in the LD Micro Main Event XVI on..
15/9/202308:51EDGAR2Form 4 - Statement of changes in beneficial ownership of..
24/8/202308:06EDGAR2Form 4 - Statement of changes in beneficial ownership of..
22/8/202306:34EDGAR2Form 4 - Statement of changes in beneficial ownership of..
22/8/202306:34EDGAR2Form 4 - Statement of changes in beneficial ownership of..
22/8/202306:34EDGAR2Form 4 - Statement of changes in beneficial ownership of..
15/8/202307:29EDGAR2Form 8-K - Current report
15/8/202306:39EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
15/8/202306:05GLOBENEXGEL Reports Second Quarter 2023 Record Revenue of $1.17..
02/8/202323:00GLOBENEXGEL to Report Second Quarter 2023 Financial Results on..
19/7/202323:10GLOBENEXGEL Partners with Enigma Health to Distribute its Leading..
15/6/202323:00GLOBENEXGEL to Participate in Maxim Group’s Virtual Healthcare..
24/5/202323:00GLOBENEXGEL to Participate in the LD Micro Invitational XIII on..
16/5/202306:05GLOBENEXGEL Reports First Quarter 2023 Financial Results
09/5/202323:15GLOBENEXGEL to Report First Quarter 2023 Financial Results on May..

Your Recent History

NASDAQ
NXGL
NexGel
Delayed Upgrade Clock
ADVFN Logo

Australia
Company
Business
Popular
Get The App

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved